Turbo cancers - Hyperprogressive Disease, Unveiling Molecular Links and IgG4 Antibody Impact

How IgG4 is involved in turbo cancersПодробнее

Human gain-of-function MC4R genetic variants show signalling bias and protect against obesityПодробнее

The Evolution of mRNA Tumor VaccinesПодробнее

Keynote Lecture 3: Understanding the relevant immune mechanisms in GI cancerПодробнее

What are turbo cancers? Part 1: IgG4 effect on immune cells (update 136)Подробнее

IgG4 role in cancer - Dr. Raszek new publication (IgG4 part 17, update #147)Подробнее

Turbo cancers part 2: the role of IgG4! (update #139)Подробнее

What is hereditary cancer? - HALO Genetic Health PathWayПодробнее

Tumor vaccines, oncolytic viruses and CAR TПодробнее

Neuroimmunological adverse events associated with immune checkpoint inhibitorsПодробнее

Pitch 7 ImmunoTechПодробнее

Cancer Vaccines: Jump Starting an Immune Response to CancerПодробнее

Cancer ImmunotherapyПодробнее

What are Immune Checkpoints?Подробнее

AKT inhibitors: a new type of targeted cancer drugПодробнее

Targetable immune checkpoint molecules in lung cancerПодробнее

Cancer immunotherapy | The PD-L1 pathwayПодробнее

Immune Checkpoint Inhibitors & Co-Stimulatory Molecules | Presented by Dr. Philippe BedardПодробнее